<DOC>
	<DOCNO>NCT02059967</DOCNO>
	<brief_summary>This phase I trial study side effect best dose image-guided adaptive radiation therapy use active breathing control give together chemotherapy simultaneous integrate boost treat patient stage IIA-IIIB non-small cell lung cancer remove surgery . Image-guided adaptive radiation therapy aim radiation therapy right tumor high radiation dos give without cause bad side effect . Giving high dos may help control tumor well . Breathing cause organ tissue , include tumor , move within chest . Active breathe control may reduce volume need treat . Drugs use chemotherapy , paclitaxel carboplatin , work different way stop growth tumor cell , either kill cell stop divide . Giving image-guided adaptive radiation therapy use active breathing control chemotherapy simultaneous integrate boost may effective treatment non-small cell lung cancer .</brief_summary>
	<brief_title>Phase I IGART Study Using Active Breathing Control Simultaneous Boost Patients With NSCLC</brief_title>
	<detailed_description>OUTLINE : This dose-escalation study IGART . Patients undergo IGART use active breathing control ( ABC ) 5 day week 7 week , total 33 fraction simultaneous integrated volume adapt boost ( SIVAB ) fraction 26-33 . Patients also receive paclitaxel intravenously ( IV ) 1 hour carboplatin IV 30 minute week 6 week . After completion study treatment , patient follow periodically 5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Histologicallyproven ( biopsy cytology ) , unresectable inoperable lung cancer follow histologic type : squamous cell carcinoma , adenocarcinoma , large cell carcinoma , nonsmall cell carcinoma otherwise specify . The tumor stage must Stage IIAIIIB ( AJCC 7th edition ) . See http : //aboutcancer.com/AJCC 7th lung 1.gif http : //aboutcancer.com/AJCC 7th lung 2.gif staging . All detectable tumor must encompass radiation therapy field . 18fluorodeoxyglucose PET require stag treatment planning . Atelectasis , present , must involve less complete lung . Laboratory value : Neutrophils &gt; 1500/µL Platelets &gt; 100,000/µL Bilirubin &lt; 1.5 mg/dL Aspartate aminotransferase ( AST ; formerly serum glutamic oxaloacetic transaminase [ SGOT ] ) &lt; 2x upper limit normal Alanine aminotransferase ( ALT ; formerly serum glutamic pyruvic transaminase [ SGPT ] ) &lt; 2x upper limit normal Serum creatinine &lt; 2.0 mg/dL Glomerular filtration rate ( GFR ) calculate ( kidney function test ) within 30 day must ≥ 59 mL/min Pulmonary function test ( PFT ) FEV1 ≥ 1.0 L/sec Plan curative radiotherapy without concurrent chemotherapy . Karnofsky Performance Scale score ≥ 70 % . Age ≥ 18 year old . Measurable disease planning CT . Patient must complete IMRT plan 66 Gy 2 Gy fraction ≥ 95 % PTV cover prescription dose , attend physician must review approved DVHs follow : total lung V20 Gy ≤ 30 % mean esophageal dose ≤ 34 Gy esophageal plan organsatrisk volume ( PRV ) V60 Gy ≤ 30 % heart V40 Gy ≤ 50 % maximum brachial plexus dose ≤ 66 Gy maximum spinal cord PRV dose ≤ 50 Gy maximum aorta dose ≤ 66 Gy maximum main bronchus dose ≤ 66 Gy maximum dose ≥ 66 Gy allow one lobar bronchus . Ability understand willingness sign write informed consent document . Complete tumor resection , recurrent disease , patient eligible definitive surgery . Prior radiation therapy thorax . Previous chemotherapy previous biologic response modifier current lung cancer within past 5 year . Clinically significant pleural effusion , pericardial effusion , superior vena cava syndrome . Oxygen supplementation require therapy . Involvement brachial plexus , infiltration aorta , heart , esophagus . Tumors affect one lobar bronchus , except second involved bronchus right middle lobe bronchus . Unable perform BH procedure , unless tumor motion ≤ 3 mm . Myocardial infarction within last 6 month , symptomatic heart disease , uncompensated chronic obstructive pulmonary disease ( COPD ) , uncontrolled bronchospasm . History prior malignancy patient disease free minimum 2 year , adequately treat basal/squamous skin cancer situ cervix cancer situ malignancy . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Lung</keyword>
</DOC>